Bipolar I Disorder

Find out more about Visual Storytelling:

Introducing a novel drug class

In order to establish a new product in the competitive antipsychotic market, our client wanted to produce a scientific 3D animation film with a very modern look and feel. The product had been launched previously, but market shares were not developing as expected. With the advent of new treatment guidelines from the American Psychiatric Association, the aim now was to clearly define the specific treatment niche in a subset of bipolar I patients. As with many antipsychotics, the detailed mode of action of the product was not known. Therefore, the very complex receptor binding properties had to be highlighted to differentiate the compound from its competitors.